ライフサイエンスコーパス: symptom

1 lopia is believed to be a common eye-related symptom.

2 h post-traumatic stress disorder (PTSD)-like symptoms.

3 ure reduced the susceptibility for PTSD-like symptoms.

4 ions with CRS cases who did not report these symptoms.

5 se, with no further clinical or radiological symptoms.

6 gdala CBF correlated with reduced depressive symptoms.

7 he measures indicate greater severity of the symptoms.

8 ing to their ninth decade without developing symptoms.

9 2 patients (20.8%) had borderline depressive symptoms.

10 g more commonly used in patients with severe symptoms.

11 elease of soluble mediators causing allergic symptoms.

12 Our primary outcome was overall change in symptoms.

13 with CMA with predominantly gastrointestinal symptoms.

14 patients with PAH and angina or angina-like symptoms.

15 involve the central nervous system with few symptoms.

16 to investigate aspects of AD related to ADHD symptoms.

17 remia is chosen on the basis of duration and symptoms.

18 follow-up, and alert providers to hepatitis symptoms.

19 ded iCBT is effective in treating depressive symptoms.

20 limited time but without noticeable clinical symptoms.

21 white matter structure to neurodevelopmental symptoms.

22 conventional therapies and help ease patient symptoms.

23 ate level, was associated with onset of PMDD symptoms.

24 hythms, providing a mechanistic link to DSPD symptoms.

25 us diagnosed 3 weeks before the onset of GCA symptoms.

26 plaque necrosis and the presence of ischemic symptoms.

27 ty was positively correlated with depressive symptoms.

28 rom baseline without inducing bradycardia or symptoms.

29 90% relief of obstruction and improvement in symptoms.

30 ing in Finnish patients with RIDDLE syndrome symptoms.

31 rting a mean of 16.6 of these characteristic symptoms.

32 l CSD recorded by fMRI during bilateral aura symptoms.

33 functional disability, with minimal clinical symptoms.

34 rapidly progressive dementia and sympathetic symptoms.

35 lesions as well as subjective improvement of symptoms.

36 ia impaired cognition and increased negative symptoms.

37 estion with typical rapid onset IgE-mediated symptoms.

38 /VF without ECG documentation at the time of symptoms.

39 The most frequent symptoms were general symptoms (324 [40%] patients), musculoskeletal pain (303

40 young adulthood) had similarly low levels of symptoms across most ages and outcomes.

41 ated to behavior, self-esteem and depressive symptoms adjusted for infant characteristics (sex, gesta

42 ural signatures of risk for maintaining PTSD symptoms after trauma exposure.

43 Negative and positive symptoms also worsened (Cohen's d values, 0.45-0.73).

44 rstanding of the heterogeneity of presenting symptoms among patients with NETs might permit more tail

45 py displayed rapid induction of upper airway symptoms, an enrichment of ILC2s, eosinophils, and neutr

46 of studies emerged: workup of patients with symptoms and biomarker findings suggestive of NET, but w

47 ocally to the nasal mucosa allowing clinical symptoms and biospecimens such as peripheral blood to be

48 on of lactate during hypoglycemia suppresses symptoms and counterregulation while preserving cognitiv

49 schools was associated with increased asthma symptoms and decreased lung function.

50 halitis virus (VEEV), which elicits flu-like symptoms and encephalitis in humans, with an estimated 1

51 umber of eosinophils in biopsies, changes in symptoms and endoscopic features are becoming important

52 After 1 year, her symptoms and her laboratory data were improved.

53 ontaneous ileitis that resembled human CD in symptoms and histology.

54 allergic diseases and in the development of symptoms and impairment in individual patients.

55 Medication then reduced symptoms and lessened the need for compensation, thereby

56 cingulo-insular alterations for FND and PTSD symptoms and may advance our understanding of FND.

57 ations, which leads to worsening of clinical symptoms and may result in a sustained decline in lung f

58 of PET imaging is a valid marker of clinical symptoms and neurodegeneration.

59 plaining the interval delay between maternal symptoms and observed fetal malformations following infe

60 ncidence and severity of 15 gastrointestinal symptoms and overall symptoms were measured daily for 7

61 ted online patient-reported outcome surveys (symptoms and quality of life) 3 to 7 days before surgery

62 erated for all moderate to severe scores for symptoms and quality of life.

63 tients on a 4-week LFM diet had improved IBS symptoms and reduced fecal LPS levels.

64 and weight loss appears to improve psoriasis symptoms and severity.

65 airs Hospital with a wide variety of dry eye symptoms and signs (ranging from none to severe).

66 Our analysis illustrates that classic symptoms and signs were common among patients with botul

67 Depressive symptoms and stronger social connectedness were associat

68 ciation between treatment delay and residual symptoms and the lack of improvement in treatment delay

69 nature of the relationship between childhood symptoms and the underlying neurodevelopmental processes

70 logical tolerance, and reducing the clinical symptoms and the use of medication.

71 s review aimed to describe core constipation symptoms and their frequency patterns among the Asian ad

72 Patients with documented moderate or severe symptoms and villous atrophy (villous height:crypt depth

73 ient demographics, comorbidities, presenting symptoms and vision, vitreoretinal findings, treatment r

74 brillation (VF) and Brugada syndrome-related symptoms, and 72 (group 2) having inducible VT/VF withou

75 F, New York Heart Association class II to IV symptoms, and a left ventricular EF of 40% or less to tr

76 measures of intelligence, anxiety/depressive symptoms, and executive function (differences of 0.6-0.7

77 severe symptoms, patients with mild/moderate symptoms, and healthy subjects.

78 mood, post-traumatic stress disorder (PTSD) symptoms, and QOL 6 months post-transplant.

79 nths post-transplant, we assessed mood, PTSD symptoms, and QOL with the Hospital Anxiety and Depressi

80 ge, sex, body mass index, physical activity, symptoms, and radiographic osteoarthritis features (Kell

81 more symptomatic, present with more atypical symptoms, and report worse quality of life in comparison

82 For each helminthiasis, known risk factors, symptoms, and suggested options for screening and treatm

83 f risk, data specific to patient occupation, symptoms, and travel history were often unavailable to t

84 RESULT: Overall, the visual symptoms are high among Thangka artists.

85 trocardiogram and an troponin if any cardiac symptoms are present in a patient with acute Zika infect

86 low concentrations, even before any clinical symptoms arise.

87 Adolescents who had more severe ADHD symptoms as children were more likely to initiate smokin

88 nKO mice, however, poorly represent human PD symptoms as they only exhibit mild motor phenotypes, min

89 tients' assessment of their gastrointestinal symptoms as well as treatment safety and tolerability.

90 eractive CSF secretion rates and reduces PHH symptoms, as does treatment with drugs that antagonize T

91 infection that may give rise to painful oral symptoms, as well as be a reservoir for infection at oth

92 lder men will experience lower urinary tract symptoms associated with benign prostatic hyperplasia (B

93 were associated with worsening heart failure symptoms at 1 year.

94 he proportion of patients with resolution of symptoms at 24 hours.

95 Identifying symptom-based endophenotypes across diagnoses may aid ge

96 ults, differences in airflow obstruction and symptoms between SA and NONSA persist after parenteral c

97 en mainly based on the presence of signs and symptoms, but efforts are underway to develop inexpensiv

98 ts that NMDAR antagonists relieve depressive symptoms by forming new synapses resulting in increased

99 he ERN is a treatment moderator and index of symptom change during cognitive-behavioral therapy (CBT)

100 y occur during early childhood, whereas most symptoms characteristic of schizophrenia do not appear b

101 with a dichotomous AG phenotype based on the Symptoms Checklist (SCL-90; N=3845) and a case-control s

102 d with small improvement in gastrointestinal symptoms compared with no gluten-free diet (difference l

103 ose with dementia, differences in depressive symptoms compared with those without dementia became app

104 he majority (88%) of patients had persisting symptoms compatible with heart failure (median of 13 [ra

105 atients (4.0%) had elevated ePPIX levels and symptoms consistent with protoporphyria but no detectabl

106 continued benefit, as evidenced by improved symptom control and reduced exacerbation risk.

107 Symptom control in severe asthmatics was not associated

108 Neutrophil(high) patients also had better symptom control, despite lower dose maintenance inhaled

109 s-of-function variant in KCNB1 and how these symptoms correlate with the type of variant will help cl

110 s and significantly longer for patients with symptom debut in the winter/early spring.

111 The median delay from neurological symptom debut to first hospital contact was 20 days and

112 stal tissue ischaemia and inflammation, with symptoms defining the acute painful sickle-cell crisis.

113 patients with PAH and angina or angina-like symptoms, determine the usefulness of screening with com

114 catalogued AEs from parental reports, daily symptom diaries, and dose escalations.

115 ionnaires (RCAT and RQLQ) and kept their own symptom diary from which the RTSS was calculated.

116 A daily online symptom diary on both nose and eye symptoms was complete

117 Symptoms did not add a significant increase to the pre-t

118 authors examined associations between the 12 symptom domains in the Neuropsychiatric Inventory (NPI)

119 sultation, further antibiotic prescriptions, symptom duration, and symptom severity.

120 ther acute lower respiratory tract infection symptoms, duration of abnormal peak flow, antibiotic use

121 juries (n = 289; 13%), nonspecific signs and symptoms, e.g., fever (n = 281; 13%), and gastrointestin

122 monthly, and rates of clinically significant symptom elevations were compared across groups.

123 iographic evidence of metastases and minimal symptoms, enzalutamide or abiraterone plus prednisone sh

124 be explained by sex differences in clinical symptoms, etiological models suggest that the biological

125 Also, symptom experience deteriorated more during the treatmen

126 The reduction in disease symptom expression is due to the effect of Si on some co

127 aracterized by brood mortality with specific symptoms, followed by eventual colony loss weeks later.

128 echanical hypersensitivity is a debilitating symptom for millions of chronic pain patients.

129 Main exclusion criteria were: symptoms for longer than 3 weeks, thrombus within 3 cm o

130 The percentage symptom-free days was in favour of INCS on demand (30%)

131 implicated for motor (PSP, MSA) or cognitive symptoms (FTD, ALS, PSP) in the diseases.

132 etween dysregulation of these areas and such symptoms has not been demonstrated.

133 Outcomes included symptoms, health status, and AF treatment, as well as 2-

134 Thus, the respiratory symptoms improved by the use of NPPV in children with ac

135 Remission was defined by symptom improvement and less than 15 eosinophils/high-po

136 a negative symptom report or no mention of a symptom in the EMR for patients who reported moderate to

137 ructure and multi-informant measures of ADHD symptoms in a large population-based sample of adolescen

138 se silencing of the INSR attenuated clinical symptoms in animal models of acute graft-versus-host dis

139 reduce the risk for or delay the onset of AD symptoms in APOE4 carriers.

140 tum correlated with inattention and negative symptoms in CD, and with poorer working memory and proba

141 and helps to understand how MSCs ameliorate symptoms in lupus-prone MRL.Fas(lpr) mice.

142 vide crucial insights into other behavioural symptoms in Parkinson's disease and addictions in the ge

143 have been associated with multiple non-motor symptoms in PD and have important clinical consequences,

144 strophin expression and stabilizing clinical symptoms in studies performed on a total of 12 treated g

145 eexperiencing symptoms were central to other symptoms in the acute phase, with intrusions and physiol

146 riation in the gene NKPD1 affects depressive symptoms in the general population.

147 degranulation, and Cyp c 1-induced allergic symptoms in the mouse model.

148 siological reactivity among the most central symptoms in the networks in terms of the extent to which

149 sed for Children to assess maladaptive grief symptoms in the past 4 weeks.

150 files in relation to the development of PTSD symptoms in two prospective military cohorts (one discov

151 gh risk for the development of schizophrenia symptoms, including psychosis, later in life.

152 ress Scales (DASS-21), (3) the Liver Disease Symptom Index-2.0 (LDSI-2.0) for testing disease specifi

153 recent vomiting, and gastroparesis cardinal symptom index-daily diary scores of 2.6 or more.

154 suffer from mast cell (MC) mediator-related symptoms insufficiently controlled by conventional thera

155 symptom threshold after inulin intake, peak symptom intensity correlated with peak colonic gas (r =

156 ery restaging visit by using the MD Anderson Symptoms Inventory.

157 disease (AD) pathology and expression of AD symptoms is poorly understood.

158 red-categorical outcome variables to compare symptom levels and trends between groups.

159 All subjects were monitored for respiratory symptoms, lung function, and nasal viral load.

160 Interventions were required to support symptom management.

161 voxel-based-and structural connectome-lesion symptom mapping approach, since cortical dysfunction aft

162 Symptoms may range from mild abdominal pain to life-thre

163 1.0 [0.9], respectively), closeness to other symptoms (mean [SD], 0.9 [0.3] and 1.1 [0.9], respective

164 the extent to which they occur between other symptoms (mean [SD], 1.2 [0.7] and 1.0 [0.9], respective

165 ten sensitivity, we found fructans to induce symptoms, measured by the GSRS-IBS.

166 Primary outcome was combined symptom medication score (CSMS) during grass pollen seas

167 ry clinical outcomes included organ-specific symptoms, medication-free days, rhinitis severity and as

168 The primary end point was daily combined symptom-medication scores during the 2013 pollen season

169 Patients with POTS had symptoms more frequently than patients with OH during HU

170 e behavioral therapy reduced primary anxiety symptoms more than fluoxetine and improved remission mor

171 of the time due to late manifestation of its symptoms, necessitating rigorous treatment following dia

172 cough and at least 1 lower respiratory tract symptom not requiring immediate antibiotic treatment and

173 fects of cortisol, demographics and clinical symptoms, NR3C1 variation predicted attention and workin

174 s involved in the ameliorating effects of AD symptoms observed in AD/TTR(+/-) animal models after IDI

175 an change in (1) tear osmolarity and (2) DED symptoms (Ocular Surface Disease Index [OSDI] score) bet

176 induces mechanical hypersensitivity, a major symptom of neuropathic pain.

177 ibute to the hypervigilance that is a common symptom of pathological anxiety.

178 understanding of a central yet understudied symptom of trauma-related psychopathology.

179 setron vs traditional therapy to resolve the symptoms of acute FPIES.

180 l, 180 patients with Alzheimer's disease and symptoms of agitation or psychosis were treated with ris

181 Symptoms of ASD typically occur during early childhood,

182 ersistently higher rates than UK controls of symptoms of autism spectrum disorder, disinhibited socia

183 ted with the probability of disagreement for symptoms of blurry vision, pain or discomfort, and redne

184 ess disorder is often comorbid with MDD, and symptoms of both disorders can be alleviated with TMS th

185 A case was defined as signs or symptoms of botulism in a prison A inmate with onset dur

186 t, or attention control) in individuals with symptoms of depression.

187 e DG, relamorelin significantly reduced core symptoms of DG and overall composite score compared with

188 Several symptoms of DN were ameliorated by VtE treatment in the

189 DED by a clinician or "often" or "constant" symptoms of dryness and irritation.

190 otherapy and somatic stimulation in treating symptoms of endometriosis.

191 ved from sleep diaries; polysomnography; and symptoms of fatigue, sleepiness, and depression.

192 toms were then compared in 177 patients with symptoms of gastroparesis.

193 nema ameliorated macroscopic and microscopic symptoms of IBD in the TNBS-induced colitis mouse model,

194 The symptoms of Lassa fever can be nonspecific and mimic tho

195 renal failure, hyperparathyroidism, or even symptoms of left upper limb ischemia.

196 t with rM3Ds-dSPN stimulation reproduced all symptoms of LID.

197 Symptoms of mental disorders were elicited using a semi-

198 antimicrobial resistance testing in men with symptoms of NGU as well as in their current sexual partn

199 The motor symptoms of Parkinson's disease (PD) are linked to abnor

200 in the pathogenesis or the gastrointestinal symptoms of PD.

201 HO Disability Adjustment Schedule [WHODAS]), symptoms of posttraumatic stress (measured by the Posttr

202 n skin prick testing and clinically relevant symptoms of rhinitis related to their sensitization.

203 in dilated ER vesicles.IMPORTANCE In humans, symptoms of RVFV infection mainly include a self-limitin

204 y diverse samples from strawberry exhibiting symptoms of Strawberry Green Petal (SbGP), periwinkle pl

205 Symptoms of the disease are variable and depend on the t

206 er understand its interaction with the motor symptoms of the disease.

207 showed evidence of being protective against symptoms of the three mental illnesses studied, and the

208 In women with symptoms of vaginal and/or vulvar atrophy, lubricants in

209 Attention to symptoms of weight gain and dyspnea are central tenets o

210 Sixty-six mothers (76%) reported symptoms of ZIKV infection during gestation.

211 for patients who reported moderate to severe symptoms on the ESQ.

212 n a mortality of 87.66% in vitro and reduced symptoms on tomato by up to 82.61% under greenhouse cond

213 domly assigned patients (1:1:1 stratified by symptom onset </=4 days or 5-6 days) to receive 300 mg o

214 atus defined by days between vaccination and symptom onset as the predictor.

215 with 2 reported incidents of pertussis with symptom onset between 1 January 2010 and 31 December 201

216 ted with intravenous tPA within 4.5 hours of symptom onset from 888 surveyed hospitals between June 2

217 focal dystonia evaluated within 5 years from symptom onset, enrolled in the Natural History Project o

218 iverge already at 17.8 years before expected symptom onset.

219 n-QW despite treatment within 12 hours after symptom onset.

220 patients were enrolled within 12 hours from symptoms onset.

221 symptom relief, with no differences in GERD symptoms or dysphagia.

222 t common reason for diagnostic exclusion was symptoms or impairment occurring exclusively in the cont

223 Only subjects with "active asthma" (symptoms or medication in the last year, n = 744) were a

224 hemocyanin (KLH) control proteins induced no symptoms or pathology.

225 studied 2420 patients 20 years or older with symptoms or signs consistent with STEMI at primary care

226 and surgery remains an option for those with symptoms or treatment complications refractory to medica

227 to discriminate between patients with severe symptoms, patients with mild/moderate symptoms, and heal

228 and above the effects of fatigue, depressive symptoms, physical activity, and psychomotor speed.

229 ction being a significant driver of clinical symptoms, placental Flt1 mRNA levels strongly correlate

230 erity, but few have assessed risk factors or symptom progression over time.

231 clinical examination and completed validated symptom questionnaires and the Clinical HIV-Associated N

232 ments with cardiopulmonary exercise testing, symptom questionnaires, and dobutamine stress echocardio

233 cally characterized by organic sleep related symptoms, rapidly progressive dementia and sympathetic s

234 ients with influenza who have very few or no symptoms reflects their potential for transmitting the v

235 Degree of perceived suffering from early symptom-related causes, attitudes toward early palliativ

236 A graph of disease-symptom relationships was elicited from the learned para

237 nd CNF, 90% and 95% of the patients reported symptom relief, with no differences in GERD symptoms or

238 of Neu5Ac, how typhoid toxin causes specific symptoms remains elusive.

239 the union, yet its efficacy in treating PTSD symptoms remains uncertain.

240 brothers with hematopoietic and immunologic symptoms reminiscent of Wiskott-Aldrich syndrome (WAS).

241 Disagreement was defined as a negative symptom report or no mention of a symptom in the EMR for

242 fect on the mean (SD) number and severity of symptoms reported by the child (severity: boys, 15.1 [9.

243 ize, 0.35), mean (SD) number and severity of symptoms reported by the parent (severity: boys, 11.1 [7

244 unction for 28 days or more; and one or more symptoms requiring treatment according to the Groupe d'E

245 e time from presentation to documentation of symptom resolution and recurrence within 3 months.

246 The mean (SD) time to symptom resolution was 13.8 (5.8) days in the interventi

247 han those receiving placebo to have complete symptom resolution.

248 .1 years of age) with assessment of insomnia symptoms (restlessness, difficulty falling asleep, wakin

249 ons of satisfaction with surgery with visual symptom scales at follow-up evaluations ranged from r =

250 ymptoms using the validated Gastrointestinal Symptom Score (GIS(c)).

251 doses showed a trend in reducing total nasal symptom score 15 minutes post-NAC at FUV1 and FUV2, but

252 d sexual dysfunction (International Prostate Symptom Score, International Index of Erectile Function,

253 the mean change at 1 year in the Hypothyroid Symptoms score (0.2+/-15.3 in the placebo group and 0.2+

254 this was reflected in the survival data.Mean symptom scores for pain were significantly higher in the

255 Patients, whose symptom scores of nose and eye were 0 and 1 point withou

256 s surgery (FESS) and correlate these data to symptoms scores.

257 e-spectrum psychotic disorder, and psychotic symptoms scoring at least 4 on at least one of the follo

258 Knowing the range of symptoms seen in patients with a missense or loss-of-fun

259 did not complete a daily diary of weight and symptom self-assessment and to identify predictors of di

260 puncture predicted sustained improvements in symptom severity at 3-month follow-up.

261 (84%) provided cough duration and 369 (93%) symptom severity data.

262 the magnitude of LDX-induced improvement in symptom severity predicted both direction and magnitude

263 Dystonic symptom severity significantly correlated with theta but

264 The time to maximum symptom severity varied from 1 day to more than 3 months

265 Mean symptom severity was 1.99 points in the prednisolone gro

266 Both anxiety diagnosis and symptom severity were associated with smaller right hipp

267 ibiotic prescriptions, symptom duration, and symptom severity.

268 S) scores for total and individual sinonasal symptoms, sinonasal outcome test (SNOT)-22 and Short For

269 n pneumonia among comatose ICU patients with symptoms suggesting either bacterial aspiration pneumoni

270 een inflammation and fear- and anxiety-based symptoms, suggesting that other factors are important in

271 Symptom suppression is achieved by delivering stimulatio

272 and for negative mental states and physical symptoms than for positive states.

273 eed for surgery and a greater improvement in symptoms than placebo.

274 ffects, such as sedation and depression-like symptoms, than other dopamine receptor antagonists.

275 g individuals with impairing late-onset ADHD symptoms, the most common reason for diagnostic exclusio

276 To capture the chronicity and intensity of symptoms, the Quick Inventory of Depressive Symptoms was

277 In patients who reached the symptom threshold after inulin intake, peak symptom inte

278 (CHR) for psychosis exhibit similar, subtle symptoms to those with schizophrenia (SZ).

279 Rankin Scale score (disability range, 0 [no symptoms] to 6 [death]; minimum clinically important dif

280 diseases are shifting from simple control of symptoms toward full control of these diseases (clinical

281 The primary outcome was membership in high-symptom trajectories of 1) conduct disorder and 2) hyper

282 ve of this study was to assess the change in symptoms using the validated Gastrointestinal Symptom Sc

283 ure-proven UTI among pregnant women with UTI symptoms was 4%.

284 Clinical success for fibroid-related symptoms was 78.6% (282 of 359).

285 symptoms, the Quick Inventory of Depressive Symptoms was administered bimonthly, and rates of clinic

286 ly online symptom diary on both nose and eye symptoms was completed.

287 nce of bacteremia in the absence of clinical symptoms was notable, and markedly different from that s

288 Reproduction of symptoms was reported by nine (1%) of 750 patients durin

289 PTSD symptoms were assessed in the emergency department and 1

290 Reexperiencing symptoms were central to other symptoms in the acute pha

291 ts from a large family with early-onset pain symptoms were evaluated by clinical examination and geno

292 Most commonly reported symptoms were exertional dyspnea (78%) and fatigue (73%)

293 The most frequent symptoms were general symptoms (324 [40%] patients), mus

294 of 15 gastrointestinal symptoms and overall symptoms were measured daily for 7 days before the study

295 Although no symptoms were noted after an exercise challenge combined

296 Ongoing bowel symptoms were present in 16.3% of patients with IBD and

297 IMD(0), GES, water load testing, and symptoms were then compared in 177 patients with symptom

298 Most patients suffered symptoms when peach trees had leaves, specifically durin

299 f low-dose naltrexone resulted in flaring of symptoms, which cleared within 2 to 3 days on rechalleng

300 Pulmonary symptoms with eosinophilia are most common, though 1 cas